APA (7th ed.) Citation

Kyriazopoulou, E., Poulakou, G., Milionis, H., Metallidis, S., Adamis, G., Tsiakos, K., . . . Giamarellos-Bourboulis, E. J. (2021). Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: A double-blind, randomized controlled phase 3 trial. Nature medicine, 27(10), 1752-1760. https://doi.org/10.1038/s41591-021-01499-z

Chicago Style (17th ed.) Citation

Kyriazopoulou, Evdoxia, et al. "Early Treatment of COVID-19 with Anakinra Guided by Soluble Urokinase Plasminogen Receptor Plasma Levels: A Double-blind, Randomized Controlled Phase 3 Trial." Nature Medicine 27, no. 10 (2021): 1752-1760. https://doi.org/10.1038/s41591-021-01499-z.

MLA (9th ed.) Citation

Kyriazopoulou, Evdoxia, et al. "Early Treatment of COVID-19 with Anakinra Guided by Soluble Urokinase Plasminogen Receptor Plasma Levels: A Double-blind, Randomized Controlled Phase 3 Trial." Nature Medicine, vol. 27, no. 10, 2021, pp. 1752-1760, https://doi.org/10.1038/s41591-021-01499-z.